Overview
- The World Health Organization reported roughly 1,561 confirmed cases and 506 deaths in early July and government figures on Wednesday showed the toll rising to about 1,708 cases and 580 deaths, signaling the outbreak is still growing.
- Health officials say the outbreak is driven by the Bundibugyo Ebola variant, for which there is no licensed vaccine or proven targeted treatment, unlike prior DRC outbreaks caused by the Zaire strain.
- Response efforts are hampered by active armed groups, attacks on health facilities and high population movement that include sick miners traveling for care, and some treatment centers are operating near full capacity with about 90% occupancy.
- The WHO has authorized the first molecular test for this outbreak and begun recruiting volunteers in the DRC to test two existing drug molecules, including the antiviral remdesivir, as investigators seek any treatment that can improve survival.
- The virus has crossed borders with cases and deaths reported in Uganda and one linked case in France, raising regional public‑health and humanitarian risks such as displacement, food and water shortages, and the spread of misinformation that undermines containment.